Medical Ethics
RSSArticles
-
Guest Column: Pharmaceutical marketing practices face new scrutiny
-
Doctors faces charges for Oxycontin ’scripts
-
Once more, with feeling: Wrong-site surgery is still an unsolved problem
-
Errors: What we have is a failure to communicate
-
Found: 13-inch retractor was left inside a patient
-
Streamline procedures to lower odds of big errors
-
Bioterrorism plans grow from variety of sources
-
Health system develops real-time bed management
-
One-page checklist saves time for IRB staff
Investigators and student researchers repeatedly called the IRB at the University of the Incarnate Word, asking the same questions, and IRB reviewers complained of continually seeing the same mistakes. Clearly, it was time to make IRB office system and procedural changes. -
Legislation for physician payment disclosure
Sen. Chuck Grassley (R-Iowa) and Sen. Herb Kohl (D-WI) have introduced legislation that would require not only pharmaceutical companies, but also makers of medical devices and biologics, to publicly report any money over $100 that they give to physicians within a year.